Updated July 2026 · 8 min read

Calciphylaxis for ICU Nurses 2026 — The Skin Emergency of Kidney Failure That Kills From the Wound In

Part of the ICU Emergencies Hub — browse every related guide in one place.

A dialysis patient shows you a patch on the thigh that started as a bruise-like mottling and has turned into a black, leathery ulcer with a violet, net-like border — and the pain is so far out of proportion to what you are looking at that morphine barely touches it. This is calciphylaxis, and it is one of the most feared complications in the kidney-failure population. It is not a simple pressure sore or a bad case of cellulitis; it is calcium literally plugging the small arteries that feed the skin and fat, choking the tissue to death from the inside. For the ICU nurse it demands recognition, aggressive pain management, meticulous wound care, and an understanding of the metabolic fire underneath — because the reported one-year mortality rivals that of many cancers.

What is actually happening in the skin

The problem lives in the tiny arterioles that supply the dermis and the fat beneath it. In calciphylaxis, calcium salts deposit in the walls of these vessels, the lining is injured, and small clots form inside them. The result is that the skin and fat downstream lose their blood supply and die — ischemic necrosis in the exact place you can see it. That is why the lesions look the way they do: they begin as tender, mottled, reddish-violet patches (often described as livedo reticularis, a net-like discoloration) and progress to firm, exquisitely painful nodules and then to black eschar surrounded by an angry purple rim. Because it is an ischemic process in fat-rich areas, the lesions favor the thighs, abdomen, buttocks, and other fatty regions, and the more central (proximal) the lesions, the worse the prognosis tends to be. The pain is a defining clue: it is severe, unrelenting, and typically out of proportion to the visible wound, because ischemic tissue and nerves are screaming before the skin has even broken down.

The metabolic fire underneath: calcium, phosphate, and PTH

Calciphylaxis is a disease of the kidney-failure metabolic environment, and understanding that triangle is what lets the nurse connect the labs to the wound. Failing kidneys cannot excrete phosphate, so phosphate rises; the high phosphate and low activated vitamin D drive the parathyroid glands to pump out parathyroid hormone (secondary hyperparathyroidism); and the whole system tips toward depositing calcium and phosphate where they do not belong — including in the walls of small blood vessels. Several things push a vulnerable patient over the edge, and many of them are on the medication list.

The warfarin link is worth flagging because it is actionable and counterintuitive: warfarin blocks a vitamin-K-dependent protein (matrix Gla protein) whose job is to stop soft-tissue calcification, so anticoagulating a dialysis patient with warfarin can both trigger and worsen calciphylaxis. That is why one of the first steps is usually stopping warfarin and switching to an alternative anticoagulant if one is still needed.

The nurse's role: pain, wounds, and infection

Day to day, calciphylaxis is won or lost on three fronts the nurse owns. First, pain: this is among the most painful conditions in medicine, and undertreating it is both cruel and clinically wrong. Expect a multimodal plan — opioids often at high doses, plus adjuncts — and advocate loudly when it is inadequate; a patient writhing with a dressing change needs the plan escalated, not a lecture on tolerance. Second, wound care: dressings, debridement decisions, and offloading are coordinated with wound and surgical teams, and the guiding principle is protecting fragile, poorly perfused tissue while preventing the wound from becoming the entry point for sepsis. Third, infection surveillance: the single biggest killer in calciphylaxis is wound infection progressing to sepsis, so every assessment watches for spreading erythema, purulence, odor, fever, or a rising white count, and treats new signs as an emergency.

Fixing the chemistry and the sodium thiosulfate piece

Alongside the wound, the team attacks the metabolic drivers. That means driving phosphate down with non-calcium binders and adequate dialysis, avoiding adding calcium load, and managing the hyperparathyroidism (with agents that lower PTH, and sometimes parathyroidectomy in refractory cases). Dialysis prescriptions are often intensified and calcium in the dialysate adjusted. The most recognized targeted therapy is intravenous sodium thiosulfate, frequently given during hemodialysis sessions; it is thought to help dissolve the calcium deposits and act as an antioxidant/vasodilator, and while the evidence base is imperfect it is a mainstay of treatment. For the nurse, the practical points are knowing that thiosulfate is typically infused with dialysis, watching for its side effects (nausea and a metabolic acidosis are common), and understanding that it works slowly — over weeks — so it is a marathon, not a rescue drug. Stopping warfarin, correcting the minerals, and thiosulfate all work on the same underlying process; none of them acts overnight.

The nursing bottom line

Calciphylaxis is calcium plugging the skin's small arteries in kidney-failure patients, producing black, agonizingly painful necrotic lesions in fatty areas and killing mainly through wound sepsis. Recognize it in the dialysis patient — especially one on warfarin — who develops a painful, net-patterned or ulcerating skin lesion with pain out of proportion to the wound. The care that matters is relentless: aggressive multimodal pain control, meticulous infection-focused wound care, correcting the calcium-phosphate-PTH derangement, IV sodium thiosulfate with dialysis, and stopping warfarin. It is a high-mortality diagnosis, and the nurse's vigilance over the wound and the pain is central to whether the patient survives it.

Related: Necrotizing fasciitis

Educational content for licensed clinicians. Always follow your facility's protocol and provider orders. Not medical advice.